❗May the 2023 be the year of psychedelics❗ ✔️More robust data are supporting the efficacy of compounds.👏 ✔️The US is expected to get near to the approval for medicinal use of psychedelics.👏 Towards the legalisation of psychedelic therapies in the EU!🇪🇺 greenmarketreport.com/2023-will-be-t…

Regulators Mikuláš Peksa 🇪🇺 🇺🇦, Florence Butlen-Ducuing, experts, and our members Eric Vermetten took part in the conference held under the EU Council🇪🇺 On this occasion, a memorandum addressing amongst the others a need for psychedelic therapies was adopted.👏 euractiv.com/section/all/ne…

According to European Commission🇪🇺 a comprehensive approach to mental health🧠 is to be out at the end of June.👏 We will continue in our efforts to secure that the medicinal use of psychedelics will be an integral part of it. Let’s work together!🤝 ec.europa.eu/transparency/d…

Time to speak up❗🔊 European Commission 🇪🇺 seeks feedback ahead of the upcoming comprehensive approach to mental🧠 health. We will emphasize evidence on psychedelics and their compassionate use.🌟 Let us know for advice on how to make use of this opportunity for your project!

❗Breaking news❗ Australia is reclassifying MDMA and psilocybin to allow psychiatrists to prescribe these substances for treatments of depression and PTSD. Psychedelic therapies are becoming legal and the European Commission🇪🇺 should be aware of this. tga.gov.au/news/media-rel…

Feedback to the European Commission🇪🇺 call for evidence on EU comprehensive approach to mental health submitted.✅ The EU policy-makers should listen to the scientific findings🔬 on the therapeutical potential of psychedelics when developing EU initiative on mental health.🧠

We are glad to hear from Stella Kyriakides that the Comprehensive approach to mental health expected in June 2023 is just a starting point.✅ New initiatives on mental health🧠 should follow, including the much-needed innovative🔬 treatments for the benefit of EU citizens.

As MDMA inches closer to becoming an approved medicine in the US it is important to understand how the therapies👩‍⚕️👨🏽‍⚕️ can be combined with MDMA effects on body and brain🧠 to support healing. The European Commission🇪🇺 should follow closely these developments. businessinsider.com/what-is-mdma-m…

❗Ayahuasca could treat depression.❗ DMT’s ability to make brain activity🧠 more fluid is thought to support the promising results🔬 from early clinical trials where patients were given DMT in combination with psychotherapy to treat depression.👏 theguardian.com/science/2023/m…

We applaud👏 the statement by Florence Butlen-Ducuing from EU Medicines Agency🇪🇺 on psychedelics🍄: “There are some trials indicating some promising effects, but we really need to understand better how they work and how they can be safely administrated to patients.” 🔬🧠

Great news! Spain prioritizes mental health for the upcoming EU Council Presidency. Starting this summer, medicinal use of psychedelics shall be put on the spotlight of Brussels discussions. A science-based comprehensive EU mental health strategy must include psychedelic therapy.

💊EMA Chief Medical Officer acknowledges difficulties in EU approval process for psychedelics. Globally, many promising phase I-III psychedelic trials exist, most outside EU. Happy to see EU key players taking note of this imbalance. Hope this will spill over into member states.

Let's not forget how effective psychedelic medicines can be.

Bringing together policymakers across party lines with high-level experts (scientists, regulators) is a major milestone towards establishing an MEP advocacy group for the medical use of psychedelics.

The final step of a long journey: The establishment of an MEP Advocacy Group for the Medical Use of Psychedelics is imminent.

MEPs and top experts discussing the potential of psychedelic therapies. Event co-organized by @psychedelicseurope just started in European Parliament. Establishment of the MEP Action Group for the Medical Use of Psychedelics to be announced.

🎉It's happening! We helped set up the European Parliament Action Group for the Medical Use of Psychedelics🌍🇪🇺. Thanks to the co-chairing MEPs Alex Agius Saliba Frédérique Ries Mikuláš Peksa 🇪🇺 🇺🇦 Sara Cerdas @saracerdas.bsky.social Tomáš Zdechovský and member MEPs Alviina Alametsä Jarosław Duda-Latoszewski Robert Biedroń

💪Powerful words from MEP Alex Agius Saliba🇪🇺 During last week's event "Psychedelic Therapies: Learn Directly from Leading European Experts" which marked the launch of the MEP Action Group on the Medical Use of Psychedelics, MEP Alex Agius Saliba delivered an inspiring speech,

Recently met with MEP Alex Agius Saliba, co-chair of the new MEP Action Group for the Medical Use of Psychedelics. It's super important to discuss the overlaps between innovative therapies and key EU strategies (e.g. Comprehensive Approach to Mental Health, Pharmaceutical Strategy

💡Psychedelic Spotlight: Ibogaine💡 While comprehensive in many aspects, the EU's mental health strategy has yet to fully address the rising issue of addiction disorders. Ibogaine could potentially play a significant role in this context. Given the EU's commitment to